Revenue
No reported data
BRIGHT MINDS BIOSCIENCES INC. (DRUG)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
Financial statements
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Research & development | $1.2M | $5.0M | $12.2M | $6.3M | $354,852 |
| Net income | −$2.8M | −$7.4M | −$15.0M | −$8.7M | −$480,377 |
| Basic EPSper diluted share | -CA$0.65 | -CA$1.98 | -CA$6.06 | -CA$4.82 | -CA$0.13 |
| Diluted EPSper diluted share | -CA$0.65 | -CA$1.98 | -CA$6.06 | -CA$4.82 | -CA$0.13 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 28, 2026Form 4 | Cormorant Asset Management, LP +2Other | SellCommon Shares · indirect | 109.3K | $89.50 | $9.79M | 950.0K |
| Nov 4, 2024Form 4 | Cormorant Asset Management, LP +1TenPercentOwner | BuyCommon Shares · indirect | 184.3K | $21.70 | $4.00M | 1.06M |
| Oct 16, 2024Form 4 | Cormorant Global Healthcare Master Fund, LP +2TenPercentOwner | BuyCommon Shares · indirect | 3.1K | $25.22 | $78.4K | 875.0K |
| Oct 16, 2024Form 4 | Cormorant Global Healthcare Master Fund, LP +2TenPercentOwner | BuyCommon Shares · indirect | 7.2K | $24.03 | $171.8K | 871.9K |
| Oct 16, 2024Form 4 | Cormorant Global Healthcare Master Fund, LP +2TenPercentOwner | BuyCommon Shares · indirect | 39.7K | $23.22 | $922.8K | 864.7K |